is admitted with COVID-19. His symptoms began 2 weeks ago. He is on high flow oxygen but NOT immunocompromised.
What is the best treatment option?
A. Baricitinib + steroidB. RemdesivirC. Remdesivir + steroidD. Azithromycin
Baricitinib + steroid
Explanation: The archived NIH COVID-19 guidelines make recommendations based on oxygen requirements, risk factors for severe disease and bleeding risk π©Έ Our patient is on high flow O2, so he should get dexamethasone + baricitinib. Remdesivir is unlikely to help >10 days after symptom onset.Empiric antibiotics are NOT recommended β Appropriate immunomodulatory therapy is associated with β¬οΈ secondary bacterial infections. Stabilizing and discharging patients quickly helps support antimicrobial stewardship π